Clinical Trial Update: Neuroprotectant for Hypertensive Intracerebral Hemorrhage [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for a neuroprotectant intended to treat hypertensive intracerebral hemorrhage; current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• Neuroprotectant

Snippet

Sponsor: Rong Hu, MD | Conditions: Intracerebral Hemorrhage | Phase 3 | Status: UNKNOWN